2023-06-25 12:54:00
The Butantan Institute announced the sequence of recruitment by volunteers for the second phase of the clinical trial of ButanVac, a vaccine developed in Brazil against Covid-19. For the sequence of tests, it is necessary to have 400 volunteers. However, so far, only 70 vacancies are filled.
The second stage will focus on proving that the vaccine is capable of generating antibodies, even in those who have previously been vaccinated. In the first phase, ButanVac proved to be safe and to induce the production of antibodies against the coronavirus.
How to participate?
If you are interested in being a research volunteer, requirements include being over 18 years old, having stable medical conditions and having already received four doses of any vaccine against SARS-CoV-2.
To enroll, you must look for one of the participating centers and express your willingness to take part. You can consult the list of locations and how to get in touch here.
Technology 2.0
ButanVac was announced in March 2021, as a vaccine that uses a “technology 2.0”, as defined by the director of Butantan at the time, Dimas Covas. Its production works by inoculation in an embryonated egg, using the viral vector technique.
The immunizer uses the inactivated Newcastle Disease virus – which only infects birds, without symptoms in humans – to take the coronavirus protein and generate the production of antibodies. This process facilitates manufacturing on an industrial scale with the Institute’s current infrastructure, which makes costs cheaper.
Tech
14 May
Tech
05 May
The latest news on the new coronavirus pandemic is available on our special page dedicated to the subject, accessed through from this link. Also check out the weekly updates of cases and deaths from the disease in our Covid-19 Report.
What are your expectations for the completion of the ButanVac clinical trial? Tell us in the space below.
1687724103
#Coronavirus #ButanVac #tests #suffer #lack #volunteers #learn #participate